|
|
Post by mnkdfann on Apr 30, 2018 15:04:21 GMT -5
Very strange. It worked for me just a minute ago. Maybe try clearing your cache? Actually I think its your cache that still had the article. So you saw the old article instead of the re-direct the rest of us are getting possibly? Anything is possible, but I am using a very new computer that AFAIK never visited that site before. |
|
|
|
Post by goyocafe on Apr 30, 2018 15:12:42 GMT -5
Very strange. It worked for me just a minute ago. Maybe try clearing your cache? Actually I think its your cache that still had the article. So you saw the old article instead of the re-direct the rest of us are getting possibly? I just read that article the other day and the link worked fine. Weird. Something up with the link/site. Check out this search result from the healthline site (site search), not google. www.healthline.com/search?q1=https://www.healthline.com/diabetesmine/david-kendall-from-lilly-to-Afrezza-inhaled-insulinThe article is listed first, just past all the ads, but redirects to the Tresiba article. |
|
|
|
Post by goyocafe on May 1, 2018 8:08:12 GMT -5
Researching Healthline a bit more, I found this article from 2013. “To elaborate, we also had a roundtable discussion with various Lilly officials, who told us about their plans for developing new basal and fast-acting insulin. The details are a post in itself, but one fascinating note was how Drs. David Moller and David Kendall both insist that smart, glucose-responsive insulin is "aspirational and over-hyped on timeline," and that faster-acting insulin is what's next in the coming years.” www.healthline.com/diabetesmine/lilly-diabetes-summit-sequel-a-peek-at-insulin-giants-workings#1 Anyone who thinks he was fired has E.coli for brains. |
|
|
|
Post by boca1girl on May 1, 2018 8:29:45 GMT -5
Researching Healthline a bit more, I found this article from 2013. “To elaborate, we also had a roundtable discussion with various Lilly officials, who told us about their plans for developing new basal and fast-acting insulin. The details are a post in itself, but one fascinating note was how Drs. David Moller and David Kendall both insist that smart, glucose-responsive insulin is "aspirational and over-hyped on timeline," and that faster-acting insulin is what's next in the coming years.” www.healthline.com/diabetesmine/lilly-diabetes-summit-sequel-a-peek-at-insulin-giants-workings#1 Anyone who thinks he was fired has E.coli for brains. I thought this passage from the article was very interesting. Five years later, not much has changed. “In talking about these products, D-blogger Bennet Dunlap urged Lilly to work with doctors more on communicating that insulin can be a way to succeed in D-management, rather than using a "treat to fail" approach in resisting insulin treatment. Lilly's Patty Martin acknowledged they haven't done that well, and they plan to improve.” |
|
|
|
Post by kc on May 1, 2018 9:32:52 GMT -5
m.huffpost.com/us/entry/us_58af1626e4b0e5fdf6196f04/ampAlthough my home state of California, like several other states, will not recognize non-compete agreements, I am always surprised at how many companies still think that forcing employees to sign these them will prevent them from later working for the company’s competitors The confidentiality part of Non-Competes are enforceable and still valid. |
|
|
|
Post by kc on May 1, 2018 9:34:57 GMT -5
I was hoping to quote from a recent article concerning Dr. Kendall below: www.healthline.com/diabetesmine/david-kendall-from-lilly-to-Afrezza-inhaled-insulin#7However, when I use the web address, the article is no longer there. Does anyone have a way to contact Mike Hoskins to let him know the article isn’t there on the website at the moment or being redirected to the wrong article? Anyway, in the article Dr. Kendall was quoted as saying that he started work the next day after leaving Lilli. Dr. Kendall said that MannKind got a free week of work from him. I loved that quote because it says to me that Dr. Kendall was so excited about starting his work at MannKind, he didn’t bother to take a down week after his employment ended at Lilli. That is the kind of dedication we want to see from every employee at MannKind but especially refreshing to see it from someone so important to the company. I guess that Lily wanted the article off the net. Don't draw any attention to it. |
|
|
|
Post by kc on May 1, 2018 9:54:25 GMT -5
Researching Healthline a bit more, I found this article from 2013. “To elaborate, we also had a roundtable discussion with various Lilly officials, who told us about their plans for developing new basal and fast-acting insulin. The details are a post in itself, but one fascinating note was how Drs. David Moller and David Kendall both insist that smart, glucose-responsive insulin is "aspirational and over-hyped on timeline," and that faster-acting insulin is what's next in the coming years.” www.healthline.com/diabetesmine/lilly-diabetes-summit-sequel-a-peek-at-insulin-giants-workings#1 Anyone who thinks he was fired has E.coli for brains. I thought this passage from the article was very interesting. Five years later, not much has changed. “In talking about these products, D-blogger Bennet Dunlap urged Lilly to work with doctors more on communicating that insulin can be a way to succeed in D-management, rather than using a "treat to fail" approach in resisting insulin treatment. Lilly's Patty Martin acknowledged they haven't done that well, and they plan to improve.” Its Just INSULIN stupid.... Big Pharma likes to play games with adding stuff to the most basic treatment for diabetes. Kendall understands how Afrezza works. creating hybrid designer drugs they can charge more $$$$ for than basic insulin.
|
|
|
|
Post by goyocafe on May 3, 2018 5:41:38 GMT -5
The link in the quote above no longer returns any reference to the article with the interview with Dr. David Kendall. Two days ago the search results listed the article first. Now there is no reference to the article at all. I’ll let everyone draw their own conclusion. |
|
|
|
Post by kc on May 3, 2018 7:46:24 GMT -5
OH MY! The Internet has been cleansed of the article. Did The Eli Lily legal team have it pulled? Stay tuned the future will be interesting. Same bat channel same bat time. But his biography is still up on the company‘s website so that’s a great sign. www.mannkindcorp.com/david-kendall/ |
|
|
|
Post by centralcoastinvestor on May 3, 2018 8:18:31 GMT -5
OH MY! The Internet has been cleansed of the article. Did The Eli Lily legal team have it pulled? Stay tuned the future will be interesting. Same bat channel same bat time. But his biography is still up on the company‘s website so that’s a great sign. www.mannkindcorp.com/david-kendall/It’s not that easy to cleanse the internet of something. Very interesting. I’m glad I kept a copy of it. I thought it was a good article but there was nothing in it in my opinion that would warrant such a drastic step as to have it completely removed from the internet. Now, by having it removed, it draws much more attention to it. Why was it removed? What was in it that caused Lilly to be so concerned? Was there a clue in it about something bigger that is coming in the future? I’m going back to read it again. |
|
|
|
Post by mnholdem on May 3, 2018 8:22:11 GMT -5
Healthline was also the media outlet whose picture of the old Exubera "bong" inhaler got linked with Afrezza for at least two years. For two years, the Exubera bong would display alongside Afrezza in Google searches for "inhaled insulin". A while ago several ProBoards participated in a campaign to report this error to Google.
It makes one wonder whether Healthline personnel are actively engaged in manipulating online access to certain health information. 
|
|
|
|
Post by liane on May 3, 2018 9:39:03 GMT -5
OH MY! The Internet has been cleansed of the article. Did The Eli Lily legal team have it pulled? Stay tuned the future will be interesting. Same bat channel same bat time. But his biography is still up on the company‘s website so that’s a great sign. www.mannkindcorp.com/david-kendall/It’s not that easy to cleanse the internet of something. Very interesting. I’m glad I kept a copy of it. I thought it was a good article but there was nothing in it in my opinion that would warrant such a drastic step as to have it completely removed from the internet. Now, by having it removed, it draws much more attention to it. Why was it removed? What was in it that caused Lilly to be so concerned? Was there a clue in it about something bigger that is coming in the future? I’m going back to read it again. Can you c/p? |
|
|
|
Post by centralcoastinvestor on May 3, 2018 9:50:23 GMT -5
It’s not that easy to cleanse the internet of something. Very interesting. I’m glad I kept a copy of it. I thought it was a good article but there was nothing in it in my opinion that would warrant such a drastic step as to have it completely removed from the internet. Now, by having it removed, it draws much more attention to it. Why was it removed? What was in it that caused Lilly to be so concerned? Was there a clue in it about something bigger that is coming in the future? I’m going back to read it again. Can you c/p? mnkdfann posted it in this thread on April 30. It’s in Column 3 of this thread. |
|
|
|
Post by mounts on May 3, 2018 11:20:22 GMT -5
|
|
|
|
Post by goyocafe on May 3, 2018 11:30:04 GMT -5
Nice! I hope whoever is messing with the site content is cringing at the thought that this is getting so much attention. |
|
